Condition
Giardia Lamblia Infection
Total Trials
3
Recruiting
0
Active
1
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 3 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
1Total
P 2 (1)
Trial Status
Not Yet Recruiting1
Active Not Recruiting1
Unknown1
Clinical Trials (3)
Showing 3 of 3 trials
NCT04827537Phase 2Active Not RecruitingPrimary
Anti-protozoal Effect of Steroid Hormone 20-hydroxyecdysone
NCT06533696Not Yet RecruitingPrimary
A Comparison of Microscopy and Enzyme Linked Immunosorbent Assay for Diagnosis of Giardia Lamblia in Children, Sohag
NCT04778280UnknownPrimary
Vitamin D Estimation With Giardia Lamblia Infections
Showing all 3 trials